Search - tctmd.com

Displaying 381 - 400 of 491

Sort: Relevancy | Date

Presentation LAA 2014

Atrial Fibrillation and LAA Closure in a Patient Requiring PCI

Presenter: Matthew J. Price

July 19, 2014

Presentation LAA 2014

Atrial Fibrillation in Patient with Low Bleeding Risk

Presenter: John D. Carroll

July 19, 2014

Presentation LAA 2014

Quantifying stroke and bleeding risk in atrial fibrillation

Presenter: Stefan Bertog

July 17, 2014

Presentation

Cryptogenic Stroke and Underlying A-fib

Presenter: Tomasso Sanna

July 01, 2014

Presentation

A-fib in Patients with Cryptogenic Stroke or TIA

Presenter: D.J. Gladstone

July 01, 2014

Presentation

PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy

Presenter: David R. Holmes Jr.

June 30, 2014

Presentation

Cerebrovascular Events in 21,105 Patients with A-fib Randomized to Edoxaban Versus Warfarin

Presenter: Robert P. Giugliano

June 24, 2014

Presentation

Efficacy, Safety of Rivaroxaban vs Warfarin in Elderly Patients with Nonvalvular A-fib

Presenter: Jonathan L. Halperin

June 09, 2014

Presentation EuroPCR 2014

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Presenter: Jos? Ram?n L?pez-M?nguez

May 21, 2014

Presentation

Importance of Persistent Elevation of Cardiac Biomarkers in A-Fib: RE-LY Substudy

Presenter: Z. Hijazi

May 09, 2014

Presentation

Anticoagulant and Antiplatelet Therapy in A-fib Patients Undergoing PCI

Presenter: K. Goto

April 30, 2014

Presentation

Intracranial Hemorrhage Among Patients with A-Fib Anticoagulated with Warfarin or Rivaroxaban

Presenter: Graeme J. Hankey

April 22, 2014

Presentation Fellows 2014

LAA Closure for Nonvalvular Atrial Fibrillation

Presenter: William Gray

April 14, 2014

Presentation ECHO 2014

Clinical Decision Making in Stroke and Atrial Fibrillation (Including Closure Devices)

Presenter: James D. Thomas

April 11, 2014

Presentation

Poorly Controlled Blood Pressure Is Independently Associated with 50% Higher Risk of Stroke or Systemic Embolism in A-fib Patients

Presenter: Meena Rao

April 02, 2014

Presentation PCI Outcomes 2014

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Presenter: Christopher Granger

March 28, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

Presentation

New-Onset A-fib after Aortic Valve Replacement: Comparison of Transfemoral, Transapical, Transaortic and Surgical Approaches

Presenter: T. Tanawuttiwat

January 29, 2014

Presentation

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

Presenter: Ziad Hijazi

December 23, 2013

Presentation

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in A-fib Patients

Presenter: C.T. Ruff

December 15, 2013

Advertisement

Atrial Fibrillation and LAA Closure in a Patient Requiring PCI

Atrial Fibrillation in Patient with Low Bleeding Risk

Quantifying stroke and bleeding risk in atrial fibrillation

Cryptogenic Stroke and Underlying A-fib

A-fib in Patients with Cryptogenic Stroke or TIA

PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy

Cerebrovascular Events in 21,105 Patients with A-fib Randomized to Edoxaban Versus Warfarin

Efficacy, Safety of Rivaroxaban vs Warfarin in Elderly Patients with Nonvalvular A-fib

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Importance of Persistent Elevation of Cardiac Biomarkers in A-Fib: RE-LY Substudy

Anticoagulant and Antiplatelet Therapy in A-fib Patients Undergoing PCI

Intracranial Hemorrhage Among Patients with A-Fib Anticoagulated with Warfarin or Rivaroxaban

LAA Closure for Nonvalvular Atrial Fibrillation

Clinical Decision Making in Stroke and Atrial Fibrillation (Including Closure Devices)

Poorly Controlled Blood Pressure Is Independently Associated with 50% Higher Risk of Stroke or Systemic Embolism in A-fib Patients

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

New-Onset A-fib after Aortic Valve Replacement: Comparison of Transfemoral, Transapical, Transaortic and Surgical Approaches

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content